Antares Pharma reported $45.1M in Pre-Tax Profit for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US $ 3899M 1051M
Abbvie ABBV:US $ 6567M 197M
Adma Biologics ADMA:US $ -18.34M 1.69M
Cara Therapeutics CARA:US $ -27749000 5.63M
Cerus CERS:US $ -12.21M 3.16M
JAZZ PHA JAZZ:US $ 321.29M 19.04M
Orasure Technologies OSUR:US $ -16.03M 7.1M
Pacira Pharmaceuticals PCRX:US $ 39.79M 19.7M
Pfizer PFE:US $ 11328M 4083M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Sientra SIEN:US $ -17.98M 2.13M
Supernus Pharmaceuticals SUPN:US $ 14.72M 12.67M
Teva Pharmaceutical TEVA:IT -971000000 796M
Teva Pharmaceutical Industries TEVA:US $ 766M 253M